Australia markets close in 3 hours 4 minutes

CNBX Pharmaceuticals Inc. (8C80.MU)

Munich - Munich Delayed price. Currency in EUR
Add to watchlist
3.87650.0000 (0.00%)
At close: 05:56PM CEST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/08/2023
31/08/2022
31/08/2021
31/08/2020
Total revenue
540.239
410.165
29.958
0
7.157
Operating expenses
Research development
564.617
431.565
1,183
1,772
1,682
Selling general and administrative
670.96
909.98
1,801
828.644
1,368
Total operating expenses
1,236
1,342
2,984
2,600
3,051
Operating income or loss
-712.908
-931.38
-2,954
-2,600
-3,043
Interest expense
8.133
1.174
1.273
2.391
8.134
Total other income/expenses net
-4,356
-2,778
-1,437
-532.879
-4,356
Income before tax
-1,232
-3,710
-4,392
-3,194
-7,467
Income from continuing operations
-1,232
-3,710
-4,392
-3,194
-7,467
Net income
-1,232
-3,710
-4,392
-3,194
-7,467
Net income available to common shareholders
-1,232
-3,710
-4,392
-3,194
-7,467
Basic EPS
-0.42
-0.42
-3.59
-2.40
-12.00
Diluted EPS
-0.42
-0.42
-3.59
-2.40
-12.00
Basic average shares
8,825
8,825
1,223
1,154
1,121
Diluted average shares
8,825
8,825
1,223
1,154
1,121